These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 19120904

  • 1. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.
    Nema H, Kato M, Katsurada T, Nozaki Y, Yotsukura A, Yoshida I, Sato K, Kawai Y, Takagi Y, Okusa T, Takiguchi S, Sakurai M, Asaka M.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
    Taha AS, Angerson WJ, Knill-Jones RP, Blatchford O.
    Aliment Pharmacol Ther; 2006 Feb 15; 23(4):489-95. PubMed ID: 16441469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The prevalence of gastroduodenal mucosal injuries in aspirin users.
    Thongbai T.
    J Med Assoc Thai; 2013 Nov 15; 96(11):1423-7. PubMed ID: 24428091
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 15; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL, Cryer B, Amer F, Hunt B.
    Clin Gastroenterol Hepatol; 2007 Oct 15; 5(10):1167-74. PubMed ID: 17916545
    [Abstract] [Full Text] [Related]

  • 10. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
    Kordecki H, Kurowski M, Kosik R, Pilecka D.
    J Physiol Pharmacol; 1997 Sep 15; 48 Suppl 4():85-91. PubMed ID: 9440059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K, Shimosegawa T.
    World J Gastroenterol; 2015 Jul 07; 21(25):7709-17. PubMed ID: 26167071
    [Abstract] [Full Text] [Related]

  • 13. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.
    Lanza FL, Evans DG, Graham DY.
    Am J Gastroenterol; 1991 Jun 07; 86(6):735-7. PubMed ID: 2038996
    [Abstract] [Full Text] [Related]

  • 14. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
    Aabakken L.
    Ital J Gastroenterol Hepatol; 1999 Jun 07; 31 Suppl 1():S19-22. PubMed ID: 10379465
    [Abstract] [Full Text] [Related]

  • 15. Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction.
    Bar Dayan Y, Amital H, Levy Y, Shoenfeld Y.
    Isr J Med Sci; 1996 May 07; 32(5):288-91. PubMed ID: 8641865
    [Abstract] [Full Text] [Related]

  • 16. Does concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin? A prospective, randomised, pilot study.
    Boike JR, Kao R, Meyer D, Markle B, Rosenberg J, Niebruegge J, Stein AC, Berkes J, Goldstein JL.
    Aliment Pharmacol Ther; 2012 Aug 07; 36(4):391-7. PubMed ID: 22742578
    [Abstract] [Full Text] [Related]

  • 17. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
    Goldstein JL, Scheiman JM, Fort JG, Whellan DJ.
    J Cardiovasc Pharmacol; 2016 Aug 07; 68(2):121-6. PubMed ID: 27002280
    [Abstract] [Full Text] [Related]

  • 18. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
    Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, Okada Y, Origasa H, Ikeda Y, MAGIC Study Group.
    J Gastroenterol; 2014 May 07; 49(5):814-24. PubMed ID: 23754512
    [Abstract] [Full Text] [Related]

  • 19. Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial.
    Cryer B, Bhatt DL, Lanza FL, Dong JF, Lichtenberger LM, Marathi UK.
    Am J Gastroenterol; 2011 Feb 07; 106(2):272-7. PubMed ID: 21081908
    [Abstract] [Full Text] [Related]

  • 20. Thirty-day mortality after peptic ulcer bleeding in hospitalized patients receiving low-dose aspirin at time of admission.
    Mose H, Larsen M, Riis A, Johnsen SP, Thomsen RW, Sørensen HT.
    Am J Geriatr Pharmacother; 2006 Sep 07; 4(3):244-50. PubMed ID: 17062325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.